TheStreet home
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Pharmaceuticals

Agenus Lead
INVESTING

Agenus Shares Blast Higher on Deal with Bristol Myers

Sarepta Craters After FDA Rejection of Muscular Dystrophy Drug
INVESTING

Sarepta Higher After Progress With Muscular Dystrophy Drug Trial

Pfizer BioNTech Moderna Lead
INVESTING

Why COVID-19 Vaccines Could Be the Start of a Vaccine Revolution

Apellis Pharma Climbs on Upgrade to Overweight at JP Morgan
INVESTING

5 Top Stock Gainers for Monday: Discovery, Apellis Pharma

Apellis Pharma Climbs on Upgrade to Overweight at JP Morgan
INVESTING

Apellis Jumps on Blood Disease Treatment Approval

Bionano Genomics Lead
INVESTING

Bionano Jumps as Revenue, Margins Increase

Lucira Health Lead
INVESTING

Lucira Health Higher as At-Home COVID Test Is Sold on Amazon

Minerva Neurosciences Lead
INVESTING

Minerva Shares Soar on Positive Schizophrenia Drug Trial

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters
LATEST NEWS

FDA OKs Pfizer-BioNTech Vaccine For Use in 12- to 15-year-olds

Novavax Lead
INVESTING

Novavax Drops on Delay in Vaccine Clearance Request

Inovio Lead
INVESTING

Inovio Falls on Wider Loss; Progress Shown in COVID Vaccine Trial

Novavax Lead
INVESTING

Novavax Slips on Reported Delay to Seek FDA Vaccine Clearance

Abbvie Pfizer Lead
INVESTING

4 Top Healthcare Stocks to Buy Now

ChemoCentryx Lead
INVESTING

ChemoCentryx Nosedives on Split FDA Panel Decision

jim-cramer-on-citigroups-downgrade-of-pfizer (3)
INVESTING

Pfizer, BioNTech Submit COVID Vaccine for Full FDA Clearance

Moderna Lead
INVESTING

Buy, Sell or Avoid Moderna After the Earnings? Here's the Chart

Moderna
INVESTING

Moderna Misses Quarterly Revenue Forecast, Boosts Vaccine Sales Outlook

BioNTech and Pfizer's mRNA-based vaccine candidate BNT162b2 has proven to be more than 90 per cent effective in preventing Covid-19 infections. Photo: Reuters
INVESTING

Pfizer, Moderna Slump as Biden Supports COVID Vaccine Patent Waiver

Match Group Initiated With a 'Buy' at Jefferies
INVESTING

5 Top Stock Gainers for Wednesday: Under Armour, Match, Athenex

Biotech movers: Ionis Drops After GSK Bows Out of Partnership
INVESTING

Ionis Pharmaceuticals Drops on Wide Quarterly Loss

Shares of Cancer Therapy Company Athenex Gain Steam in IPO Debut
INVESTING

Athenex Jumps on Plan to Buy Cancer-Therapy Developer Kuur

Precipio Lead
INVESTING

5 Top Stock Gainers for Tuesday: Vaxart, Precipio, Gartner

jim-cramer-on-citigroups-downgrade-of-pfizer (3)
Video

Why Jim Cramer Would Buy Pfizer Here

Cocrystal Pharma Lead
INVESTING

Cocrystal Doubles on Report of Progress on Covid Drugs